Chitin Biology and Beyond: Chemical Biology Aiming to Enhanced Chitin Utilization and Insect Pest Control

Tamo       Fukamizo; Qing       Yang

doi:10.2174/138161282629200730113058

[1] 
Jia X, Mijanur MD, Rajib R, Yin H. Recognition pattern, functional mechanism and application of chitin and chitosan oligosaccharides in sustainable agriculture. Curr Pharm Des  2020; 26(29): 3508-21.
[2] 
Ogata M. Chemoenzymatic synthesis and function of chitin derivatives. Curr Pharm Des  2020; 26(29): 3522-9.
[3] 
Muthukrishnan S, Munb S, Noh MY, Geisbrechta ER, Arakane Y. Insect cuticular chitin contributes to form and function. Curr Pharm Des  2020; 26(29): 3530-45.
[4] 
Wang Y, Gao L, Moussian B. Drosophila, chitin and insect pest management. Curr Pharm Des  2020; 26(29): 3546-53.
[5] 
Rösner J, Wellmeyer B, Merzendorfer H. Tribolium castaneum: a model for investigating the mode of action of insecticides and mechanisms of resistance. Curr Pharm Des  2020; 26(29): 3554-68.

Download Options

Rights & Permissions Print Cite

Current Pharmaceutical Design

Title:Chitin Biology and Beyond: Chemical Biology Aiming to Enhanced Chitin Utilization and Insect Pest Control

Volume: 26 Issue: 29

Author(s): Tamo Fukamizo and Qing Yang

Affiliation:

Export Options

Export File:

RIS (for EndNote, Reference Manager, ProCite)

BibTeX

Text

Content:

Citation Only

Citation and Abstract

About this article

Cite this article as:

Fukamizo Tamo and Yang Qing , Chitin Biology and Beyond: Chemical Biology Aiming to Enhanced Chitin Utilization and Insect Pest Control, Current Pharmaceutical Design 2020; 26 (29) . https://dx.doi.org/10.2174/138161282629200730113058

DOI https://dx.doi.org/10.2174/138161282629200730113058	Print ISSN 1381-6128
Publisher Name Bentham Science Publisher	Online ISSN 1873-4286

About this journal

Call for Papers in Thematic Issues

Submission closes on : 31 December, 2025

Advances in the Molecular Pathogenesis of Inflammatory Bowel Disease.

This thematic issue will emphasize the recent breakthroughs in the mechanisms of Inflammatory bowel disease (IBD) pathogenesis and devotes some understanding of both Crohn’s and ulcerative colitis. It is expected to include studies about cellular and genetic aspects, which help to precipitate the disease, and the immune system-gut microbiome relations ...read more

Guest Editor(s): Dr. Manish Gautam

Submission closes on : 31 December, 2025

Blood-based biomarkers in large-scale screening for neurodegenerative diseases

Disease biomarkers are necessary tools that can be employ in several clinical context of use (COU), ranging from the (early) diagnosis, prognosis, prediction, to monitor of disease state and/or drug efficacy. Regarding neurodegenerative diseases, in particular Alzheimer’s disease (AD), a battery of well-validated biomarkers are available, such as cerebrospinal fluid ...read more

Guest Editor(s): Dr. Carlo Cervellati

Submission closes on : 31 December, 2025

Current Pharmaceutical challenges in the treatment and diagnosis of neurological dysfunctions

Neurological dysfunctions (MND, ALS, MS, PD, AD, HD, ALS, Autism, OCD etc..) present significant challenges in both diagnosis and treatment, often necessitating innovative approaches and therapeutic interventions. This thematic issue aims to explore the current pharmaceutical landscape surrounding neurological disorders, shedding light on the challenges faced by researchers, clinicians, and ...read more

Guest Editor(s): Dr. Sidharth Mehan

Submission closes on : 31 December, 2025

Diabetes mellitus: advances in diagnosis and treatment driving by precision medicine

Diabetes mellitus (DM) is a chronic degenerative metabolic disease with ever increasing prevalence worldwide which is now an epidemic disease affecting 500 million people worldwide. Insufficient insulin secretion from pancreatic β cells unable to maintain blood glucose homeostasis is the main feature of this disease. Multifactorial and complex nature of ...read more

Guest Editor(s): Dr. Ali Yadollahpour,